Wednesday, 20 Nov 2019

You are here

Patients Don't Always Tell the Truth

Sometimes patients withhold information from their doctors, and a new study suggests that as much as 60 - 80% of patients consciously omit information to their doctors, despite knowing this may bear on their health and well-being.

In two national online surveys of 4510 US adults and their self-reported medical behaviors, most participants reported withholding at least 1 of 7 types of medically relevant information, especially when they disagreed with the clinician’s recommendations or misunderstood the clinician’s instructions. The most commonly reported reasons for not disclosing information included not wanting to be judged or hear how harmful their behavior is.

From these 2 surveys we see that most patients were white (79-84%) with mean ages of 36 and 61 years.  Key findings included:

  • 61-81% avoided disclosing at least 1 type of information
  • 46% disagreed with the clinician’s recommendation
  • 31% did not understand the clinician’s instructions
  • 62-82% failed to disclose as they did not want to be judged or lectured
  • 61-76% not wanting to hear how harmful the behavior is
  • 59-61% not wanting to be embarrassed  

Those most likely to withhold information were women (OR 1.38-1.88), younger (OR 0.98), and have worse self-rated health (OR 0.80-0.87).

Other patient viewpoints included: 

  • I didn't want the provider to think I'm a difficult patient (51 and 38 percent)
  • I didn't want to take up any more of the provider's time (45 and 36 percent)
  • I didn't think it mattered (39 and 33 percent)
  • I didn't want the provider to think I'm stupid (38 and 31 percent)
  • I didn't want this information in my medical record (34 and 31 percent).

The authors surmised that the electronic health records may worry some about what goes into their chart.

Withholding important information from their clinicians was most likely when patients disagreed with or misunderstood their clinician’s instructions. A better understanding is needed of patients comfort and fears if we are to improve clinician-patient relationship and patient care.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Mallinckrodt Receives SEC Subpoena

Reuters reports that Mallinckrodt Plc has received a subpoena from the U.S. Securities and Exchange Commission for documents related to the drugmaker’s lawsuit against the U.S. Department of Health and Human Services (HHS).

ACR Responds to CY2020 Medicare Physician Fee Schedule Proposed Rule

Rheumatology leaders commend CMS for proposing E/M code changes and urge agency to make additional changes to final rule.d

Parenteral Out-Performs Oral Weekly Methotrexate

A systematic review in PLOS suggests that parenteral MTX therapy is more successful than oral MTX in achieving optimal disease activity control. 

ACR Survey Shows Half of Patients Cannot Afford Treatments

Americans living with rheumatic disease face significant healthcare challenges, according to a national patient survey released this week by the American College of Rheumatology. More than 1,500 U.S. adults living with rheumatic disease responded to the survey, which asked a range of questions related to healthcare access, affordability and lifestyle. Key findings include that even though 90 percent of respondents reported having health insurance coverage, nearly 60 percent said they had difficulty affording their medications or treatments in the past year.

Medical Use of Cannabis in 2019

JAMA has published an overview of cannabis and its medical uses. Although nearly 10% of cannabis users in the United States report using it for medicinal purposes, there is insufficient evidence to support the use of medical cannabis for most conditions for which its use is advocated or advised. Nevertheless, there is increase in favoring the public availability of cannabis, largely for the management of more than 50 medical conditions.